Method for cleansing fluid discharging skin surfaces, wounds and mucous membranes and means for carrying out the method
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-031/74
A61K-031/70
출원번호
US-0422660
(1982-09-24)
발명자
/ 주소
Rothman, Ulf S. E.
Jacobsson, Sten A. L.
출원인 / 주소
Pharmacia Aktiebolag
대리인 / 주소
Philpitt, Fred
인용정보
피인용 횟수 :
94인용 특허 :
0
초록
The present invention relates to a method and material for cleansing fluid discharging skin surfaces, wounds and mucous membranes, which method and material includes the use of a material comprising certain water-insoluble hydrophilic polymers.
대표청구항▼
1. A method for cleansing a fluid-discharging infected sore located on the exterior of the body, which method comprises applying thereto a particulate mass of dry water-insoluble polymer particles within the size range of 30 to 400μ, mixed with a dermatologically acceptable binder, said polymer part
1. A method for cleansing a fluid-discharging infected sore located on the exterior of the body, which method comprises applying thereto a particulate mass of dry water-insoluble polymer particles within the size range of 30 to 400μ, mixed with a dermatologically acceptable binder, said polymer particles being selected from water-soluble dextran, starch, and derivatives thereof cross-linked in aqueous solution to form a water-insoluble three-dimensional network held together by bonds of covalent nature, one gram of which swells in the presence of water to absorb approximately 1.5 to 10 grams of water, the swellability of the polymer particles in water being such that the polymeric particles in swollen state have a pore size which permits the penetration theretinto of low molecular weight materials discharging from the sore but which completely or substantially excludes penetration thereinto of materials discharging from the sore that have a molecular weight greater than about 50,000, which excluded materials migrate between the particles towards the outer boundaries of the particulate mass, thereby avoiding formation of a scab directly on the surface of the infected sore, maintaining said particulate mass in contact with said sore for a sufficient length of time to make the particles swollen and thereafter removing the resulting swollen particulate mass from contact with said sore. 2. A method according to claim 1 wherein said binder is selected from the group consisting of polyethylene glycols, carboxymethyl cellulose and gummi arabicum. 3. A method according to claim 2 wherein said polymer particles are obtained by the cross-linking of dextran, hydroxyethyl dextran, carboxy methyl dextran, sulphopropyl dextran, diethyl amino ethyl dextran, starch, hydroxyethyl starch or carboxy methyl starch. 4. A method according to claim 3 wherein the crosslinks are bridges comprising straight or branched aliphatic saturated hydrocarbon chains, bound by ether linkages, said hydrocarbon chains containing 3-20 carbon atoms and being substituted by at least one hydroxyl group and being optionally broken by one to three oxygen atoms. 5. A method according to any one of claims 1-4 wherein said polymer particles have a water adsorption ability of approximately 2 to 5 grams of water per gram of dry polymer. 6. A method according to any one of claims 1-4 wherein a disinfectant is incorporated with the polymer particles. 7. A method for cleansing a fluid-discharging infected sore, located on the exterior of the body, which method comprises applying thereon a particulate mass of dry water-insoluble polymer particles within the size range of 30 to 400μ, mixed with a dermatologically acceptable binder, said particles consisting of a water-soluble hydrophilic hydroxy-group-containing polymer comprising polymeric or polymerized carbohydrates or sugar alcohols cross-linked in aqueous solution to a water-insoluble three-dimensional network held together by bonds of covalent nature, one gram of which swells in the presence of water to absorb at least one but less than 15 grams of water, the swellability in water being such that the polymeric particles in swollen state permit penetration thereinto of low molecular weight materials discharging from the sore but completely or substantially exclude penetration thereinto of materials discharging from the sore having a molecular weight greater than 50,000, which excluded materials migrate between the particles towards the outer boundaries of the particulate mass, thereby avoiding formation of a scab directly on the surface of the infected sore, maintaining said particulate mass in contact with said sore for a sufficient length of time to make the particles swollen, and thereafter removing the resulting swollen particulate mass from contact with said sore. 8. A method according to claim 7 wherein said binder is selected from the group consisting of polyethylene glycols, carboxymethyl cellulose and gummi arabicum. 9. A method according to claim 8 wherein the polymer is cross-linked by means of bridges comprising straight or branched aliphatic saturated hydrocarbon chains bound to said polymeric or polymerized carbohydrates or sugar alcohols by ether linkages, said hydrocarbon chains containing 3-20 carbon atoms and being substituted by at least one hydroxyl group and being optitonally broken by one to three oxygen atoms, and wherein the polymer in fully water-swollen state contains more than 50% by weight of water. 10. A method according to claim 9 wherein the polymer in the fully water-swollen state contains more than 60% by weight of water and less than 90% by weight of water. 11. A method according to any one of claims 7-10 wherein said polymer particles comprising a polysaccharide polymer cross-linked to a three-dimensional network held together by bonds of covalent nature. 12. A method according to claim 11 wherein said binder is selected from the group consisting of polyethylene glycols, carboxymethyl cellulose and gummi arabicus. 13. A method according to claim 12 wherein a disinfectant is incorporated with the polymer particles. 14. A method for cleansing a fluid-dicharging infected sore located on the exterior of the body, which method comprises establishing upon the sore a gel chromatographic zone so that the various molecular weight components of the aqueous fluids exuding from the sore will migrate away from the surface of the sore and through said gel chromatographic zone to different degrees, depending on their molecular weights, said gel chromatographic zone being established by depositing upon the surface of the sore a particulate mass comprising dry particles mixed with a dermatologically acceptable binder, each of said particles: (a) consisting of a water-insoluble hydroxyl-group containing polymer, comprising polymeric or polymerized carbohydrates or sugar alcohols cross-linked to a three-dimensional network held together by bonds of covalent nature, (b) being capable of undergoing at least limited swelling to form a gel when contacted with the aqueous fluids which exude from the sore, one gram of said polymer particles being able to swell in the presence of water to absorb at least 1.0 grams of water but less than 15 grams of water, (c) being within the size range of 30 to 400μ, (d) having a pore size in a swollen state (1) that permits penetration thereinto of low molecular weight materials discharging from the sore but (2) that substantially excludes penetration thereinto of materials discharging from the sore that have a molecular weight greater than 50,000, which excluded materials migrate between the particles towards the outer boundaries of the particulate mass, maintaining said particulate mass in contact with said sore for a sufficient length of time to make the particles swollen, and thereafter removing the resulting swollen particulate mass from contact with said sore, whereby by virtue of the gel chromatographic effect obtained by absorption and migration of the aqueous fluids exuding from the sore, eschar formation is prevented directly on the liquid discharging surface of the sore, and bacteria are entrained in the components migrating from the discharging surface of the sore to a zone spaced therefrom where they do not affect the surface of the sore and where they later on are readily removed together with the gel particles. 15. A method according to claim 14 wherein said binder is selected from the group consisting of polyethylene glycols, carboxymethyl cellulose and gummi arabicum. 16. A method according to claim 15 wherein said polymer particles are selected from water-soluble dextran, starch and derivatives thereof being cross-linked in aqueous solution to form a water-insoluble three-dimensional network held together by bonds of covalent nature, one gram of which swells in the presence of water to absorb approximately 1.5 to 10 grams of water. 17. A method according to claim 16 wherein one gram of said polymer particles will swell in water to absorb 2 to 5 grams of water. 18. A method according to any one of claims 14-17, wherein a disinfectant is incorporated with the polymer particles. 19. A material for cleansing a fluid-discharging infected sore located on the exterior of the body which comprises dry water-insoluble polymer particles within the size range of 30 to 400μ, in combination with a disinfectant, said polymer particles being selected from water-soluble dextran, starch and derivatives thereof cross-linked in aqueous solution to form a water-insoluble three-dimensional network held together by bonds of covalent nature, one gram of which swells in the presence of water to absorb approximately 1.5 to 10 grams of water, the swellability of the polymer particles in water being such that the polymer particles in swollen state have a pore size which permits the penetration thereinto of low molecular weight materials discharging from a sore but which completely or substantially excludes penetration thereinto of materials discharging from a sore that have a molecular weight greater than about 50,000, which excluded materials migrate between the particles toward the outer boundaries of the particulate mass. 20. A material according to claim 19 which includes a dermatologically acceptable binder admixed with the polymer particles. 21. A material according to claim 20 wherein said binder is selected from the group consisting of polyethylene glycols, carboxymethyl cellulose and gummi arabicum. 22. A material according to claim 21 wherein said polymer particles comprise cross-linked dextran, hydroxyethyl dextran, carboxy methyl dextran, sulphopropyl dextran, deithylamino ethyl dextran, starch hydroxyl ethyl starch or carboxymethyl starch. 23. A material according to claim 22 wherein the crosslinks are bridges comprising straight or branched aliphatic saturated hydrocarbon chains bound by ether linkages, said hydrocarbon chains containing 3-20 carbon atoms and being substituted by at least one hydroxyl group and being optionally broken by one to three oxygen atoms. 24. A material according to any one of claims 19-23, wherein one gram of said polymer particles can absorb approximately 2 to 5 grams of water.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허를 인용한 특허 (94)
Leach, Michael D.; Chavarria, Jason, All-in-one means of separating blood components.
Higgins, Joel C.; Leach, Michael D.; Woodell-May, Jennifer E.; Miller, Brandon, Apparatus and method for separating and concentrating fluids containing multiple components.
Higgins, Joel C.; Swift, Matthew; Gordon, Nathan; Hecker, Barry F., Apparatus and method for separating and concentrating fluids containing multiple components.
Higgins, Joel C.; Swift, Matthew; Gordon, Nathan; Hecker, Barry F., Apparatus and method for separating and concentrating fluids containing multiple components.
Landrigan, Matthew D.; Leach, Michael D.; Higgins, Joel C., Apparatus and method for separating and concentrating fluids containing multiple components.
Landrigan, Matthew D.; Leach, Michael D.; Higgins, Joel C., Apparatus and method for separating and concentrating fluids containing multiple components.
Leach, Michael D.; Higgins, Joel C.; Swift, Matthew; Gordon, Nathan, Apparatus and method for separating and concentrating fluids containing multiple components.
Leach, Michael D.; Higgins, Joel C.; Swift, Matthew; Gordon, Nathan, Apparatus and method for separating and concentrating fluids containing multiple components.
Leach, Michael D.; Woodell-May, Jennifer E.; Higgins, Joel C.; Miller, Brandon, Apparatus and method for separating and concentrating fluids containing multiple components.
Leach, Michael D.; Woodell-May, Jennifer E.; Higgins, Joel C.; Miller, Brandon, Apparatus and method for separating and concentrating fluids containing multiple components.
Yves Delmotte BE; Arnold Bilstad ; David Amrani ; James DiOrio ; Atif M. Yardimci ; David W. Pennington ; James S. Slepicka ; Cristina Stadler, Fibrin delivery device and method for forming fibrin on a surface.
Leach, Michael D.; Higgins, Joel C.; Swift, Matthew; Gordon, Nathan, Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles.
Roufa Dikla ; Harel Adrian ; Frederickson Robert C. A., Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers.
Roufa Dikla ; Harel Adrian ; Frederickson Robert C. A. ; Coker ; III George T., Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers.
Roufa Dikla ; Harel Adrian ; Frederickson Robert C. A. ; Coker ; III George T., Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers.
Binder, Jeffrey R.; Higgins, Joel C.; Leach, Michael D.; O'Shaughnessey, Krista; Woodell-May, Jennifer E., Methods and non-immunogenic compositions for treating inflammatory disorders.
Leach, Michael D.; Woodell-May, Jennifer E.; Higgins, Joel C.; O'Shaughnessey, Krista, Methods for making cytokine compositions from tissues using non-centrifugal methods.
Leach, Michael D.; Woodell-May, Jennifer E.; Higgins, Joel C.; O'Shaughnessey, Krista, Methods for making cytokine compositions from tissues using non-centrifugal methods.
Antanavich Richard D. (Paso Robles CA) Dorian Randel (Orinda CA), Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant.
Landrigan, Matthew D.; O'Shaughnessey, Krista; Woodell-May, Jennifer E.; Suter, David L., Treatment of peripheral vascular disease using protein solutions.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.